Literature DB >> 9830985

Formation of hydroxyapatite in new calcium phosphate cements.

S Takagi1, L C Chow, K Ishikawa.   

Abstract

Tetracalcium phosphate (TTCP) has been shown previously to be an essential component of self-setting calcium phosphate cements that form hydroxyapatite (HA) as the only end-product. We report herein on a new self-setting calcium phosphate cement that does not contain TTCP. These cements consist of dicalcium phosphate anhydrous (DCPA), dicalcium phosphate dihydrate (DCPD), alpha-tricalcium phosphate, or amorphous calcium phosphate and, as an additional source of calcium, calcium hydroxide or calcium carbonate. These cements require the use of a phosphate (0.2 moll(-1) or higher) solution or a high pH solution as the cement liquid. The cements harden in relatively short time (5-30 min) and form HA as the dominant end-product in 24 h. The diametral tensile strengths of the 24-h samples are in the range of 0.2 to 7.5 MPa. Results from X-ray diffraction studies suggest that the cement setting is caused by rapid HA formation induced by the high phosphate concentration of the cement liquid. Because DCPA and DCPD are highly soluble at pH values above 12.7, which is the pK3 of phosphoric acid, high phosphate concentration in the slurry solution was also attainable by using a highly alkaline solution as the cement liquid. The physicochemical properties of these cements are comparable to those of TTCP-containing cements, and the new cements may be expected to have in vivo characteristics similar to those of TTCP-containing cements as well.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830985     DOI: 10.1016/s0142-9612(97)00119-1

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  21 in total

Review 1.  Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.

Authors:  Noam Eliaz; Noah Metoki
Journal:  Materials (Basel)       Date:  2017-03-24       Impact factor: 3.623

2.  Setting solution concentration effect on properties of a TTCP/DCPA-derived calcium phosphate cement.

Authors:  Chang-Keng Chen; Chien-Ping Ju; Jiin-Huey Chern Lin
Journal:  J Mater Sci Mater Med       Date:  2012-06-12       Impact factor: 3.896

Review 3.  Biomaterials in orthopaedics.

Authors:  M Navarro; A Michiardi; O Castaño; J A Planell
Journal:  J R Soc Interface       Date:  2008-10-06       Impact factor: 4.118

4.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

5.  Calcium silicate/calcium phosphate biphasic cements for vital pulp therapy: chemical-physical properties and human pulp cells response.

Authors:  M G Gandolfi; G Spagnuolo; F Siboni; A Procino; V Rivieccio; G A Pelliccioni; C Prati; S Rengo
Journal:  Clin Oral Investig       Date:  2015-03-31       Impact factor: 3.573

6.  Development of strong and bioactive calcium phosphate cement as a light-cure organic-inorganic hybrid.

Authors:  M Barounian; S Hesaraki; A Kazemzadeh
Journal:  J Mater Sci Mater Med       Date:  2012-04-13       Impact factor: 3.896

7.  Addition of sodium hyaluronate and the effect on performance of the injectable calcium phosphate cement.

Authors:  Dan Kai; Dongxiao Li; Xiangdong Zhu; Lei Zhang; Hongsong Fan; Xingdong Zhang
Journal:  J Mater Sci Mater Med       Date:  2009-03-17       Impact factor: 3.896

8.  The effect of premixed schedule on the crystal formation of calcium phosphate cement-chitosan composite with added tetracycline.

Authors:  Jing Mao; Yan Liu; Bin Zhou; Liyun Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-08-15

9.  Formation of macropores in calcium phosphate cement implants.

Authors:  S Takagi; L C Chow
Journal:  J Mater Sci Mater Med       Date:  2001-02       Impact factor: 3.896

Review 10.  Calcium orthophosphates: occurrence, properties, biomineralization, pathological calcification and biomimetic applications.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.